Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CAR Immunotherapy for the treatment of infectious diseases: a systematic review
Elena Morte-Romea, Cecilia Pesini, Galadriel Pellejero-Sagastizábal, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 13

Showing 13 citing articles:

Engineering strategies to safely drive CAR T-cells into the future
Matteo Rossi, Eytan Breman
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
The Efficacy of Chimeric Antigen Therapy in Viral Infectious Diseases: A Systematic Review of Randomized Controlled Trials
Hossein Hatami, Elnaz Ataei, Mohammad Javad Nasiri, et al.
Turkish Journal of Immunology (2025) Vol. 12, Iss. 3, pp. 84-91
Open Access
Expanding the Horizons of CAR-T Cell Therapy: A Review of Therapeutic Targets Across Diverse Diseases
Alejandrina Hernández-López, Alberto Olaya‐Vargas, Juan Carlos Bustamante‐Ogando, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 156-156
Open Access
A Quantitative Approach to Potency Testing for Chimeric Antigen Receptor-Encoding Lentiviral Vectors and Autologous CAR-T Cell Products, Using Flow Cytometry
Juan José Mata, Letícia Alserawan, Carolina España, et al.
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 303-303
Open Access
Precise CAR-T-cell Therapy Targeting Non-Cancerous Diseases: Advances in Precision Medicine and Bioengineering
Chaojie Zhu, Fangzhou Wang, Zesheng Cheng, et al.
Precision medicine and engineering. (2025), pp. 100024-100024
Open Access
The antiviral potential of Vγ9Vδ2 T cells: Therapeutic implications for immunocompromised adult and pediatric hosts
Veronica Bordoni, Federica Guarracino, Alessandro Lorusso, et al.
International review of cell and molecular biology (2025)
Closed Access
Diverse potential of chimeric antigen receptor‐engineered cell therapy: Beyond cancer
Lvying Wu, Lingfeng Zhu, Jin Chen
Clinical and Translational Medicine (2025) Vol. 15, Iss. 4
Open Access
Engineered Nanostructures for Sonothermal Therapy
Fatemeh Hakimi, Zhizi Ma, Narges Karimi, et al.
Advanced Functional Materials (2024)
Closed Access | Times Cited: 2
Immunomechanobiology: Engineering the Activation and Function of Immune Cells with the Mechanical Signal of Fluid Shear Stress
Nicole S. Sarna, Natalie M Curry, Ehsan Aalaei, et al.
IEEE Reviews in Biomedical Engineering (2024) Vol. 18, pp. 231-249
Open Access | Times Cited: 1
Discovery of a pan anti-SARS-CoV-2 monoclonal antibody with highly efficient infected cell killing capacity for novel immunotherapeutic approaches
Daouda Abba Moussa, Mario Vazquez, Christine Chable-Bessia, et al.
Emerging Microbes & Infections (2024) Vol. 14, Iss. 1
Closed Access | Times Cited: 1
Leveraging oncovirus-derived antigen against the viral malignancies in adoptive cell therapies
Wei Zhang, Miao Zeng, Yisheng Li, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access
Smart Cell Therapy: an industry perspective on macrophages as living drugs
David T. Rodgers, Tatiana I. Novobrantseva, Rita N. Bárcia
Cytotherapy (2024)
Closed Access
Host-directed therapies modulating innate immunity against infection in hematologic malignancies
Qiong Wang, Kristján Hermannsson, Emeline Masson, et al.
Blood Reviews (2024), pp. 101255-101255
Open Access
Page 1

Scroll to top